Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07653620 · ClinicalTrials.gov registry record · NA
Hydration & Female Life Stages
A NA study, sponsored by PepsiCo Global R&D.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT07653620 is a NA study that is actively recruiting participants, run by PepsiCo Global R&D. The registered enrollment target is 72 participants.
The verdict
NCT07653620, a NA study, is actively recruiting participants, sponsored by PepsiCo Global R&D.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
Female life stages including premenopausal, perimenopausal, postmenopausal, are characterized by changing concentrations and patterns of hormones. The premenopause stage represents the reproductive years with normal menstrual cycles lasting between 21-35 days. The perimenopause stage is the beginning of the menopause transition and can last up to 10 years. During this transition, menstrual cycles become longer and irregular in length (7 days or longer). After 12 consecutive months with no period, the transition is complete into the postmenopause stage. Hormones that change across the lifespan are known to influence systems that regulate thirst, fluid balance, and sodium balance. Yet, fluid balance across life stages remains poorly understood, with no direct comparisons across all three life stages. The purpose of this study is to evaluate the effect of female life stage on rehydration with water and electrolyte solution after overnight fast and fluid restriction
Interventions
- OTHER placebo beverage
- OTHER electrolyte beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2026-06 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07653620
The ClinicalTrials.gov registry entry for NCT07653620 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PepsiCo Global R&D, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo beverage is the first listed.
NCT07653620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07653620 about?
NCT07653620 is a clinical study titled "Hydration & Female Life Stages". Female life stages including premenopausal, perimenopausal, postmenopausal, are characterized by changing concentrations and patterns of hormones. The premenopause stage represents the reproductive years with normal menstrual cycles lasting between 21-35 days. The perimenopause stage is the beginnin...
What is the current status of trial NCT07653620?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2026-06. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07653620?
The interventions under investigation include: placebo beverage (OTHER), electrolyte beverage (OTHER).
Who is sponsoring clinical trial NCT07653620?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.